Latest news articles

Added 1 month ago Drug news

APL 130277 refiled with FDA for parkinsons disease.- Sunovion Pharma

Sunovion Pharmaceuticals announced that the FDA has accepted its New Drug Application (NDA) for APL 130277 (apomorphine sublingual film) to...

Added 5 months ago Drug news

Mitsubishi Tanabe initiates Phase III BouNDless study of ND 0612 to treat Parkinson's disease.

Mitsubishi Tanabe Pharma America announced the initiation of the Phase III BouNDless study investigating the efficacy, safety and tolerability of...

Added 5 months ago Drug news

FDA approves Nourianz for Parkinson’s disease

The FDA has granted approval for Nourianz (istradefylline), from Kyowa Kirin Co, for use as adjunctive treatment to levodopa/carbidopa in...

Search all news articles for Parkinson's disease
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EPNS 2019 Congress Highlights

EPNS 2019 Congress Highlights

The epgonline.org team is creating daily reports from the 13th European Paediatric Neurology Society (EPNS) Congress, held in Athens, Greece from 17th to 21st September 2019, to bring you coverage of cutting-edge science and advances in clinical care across all fields of paediatric neurology. 

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

Load more

Guidelines

Parkinson’s disease in adults

This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms...

Added 1 year ago

Urinary incontinence in neurological disease: assessment and management

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease.

Added 7 years ago

Diagnosis and pharmacological management of Parkinson’s disease

This guideline provides recommendations based on current evidence for best practice in the diagnosis and pharmacological management of Parkinson’s disease.

Added 10 years ago

Search all guidelines for Parkinson's disease
 

Journal articles

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia.

Background and objectives: The last version of the EFNS dementia guidelines is from 2007. In 2010, the revised guidelines for Alzheimer's disease (AD) were published. The current guidelines involve the revision of the dementia...

Added 1 month ago

Neuroimaging biomarkers of neurodegenerative diseases and dementia.

In this review, the authors describe key findings from neuroimaging studies (magnetic resonance imaging and radionucleotide imaging) in neurodegenerative disorders, including Alzheimer’s disease (AD) and prodromal stages...

Added 1 month ago

Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor Complications.

Objective: Secondary analysis to assess whether DBS affects these symptoms within a large randomized controlled trial comparing DBS of the STN combined with best medical treatment and best medical treatment alone in patients...

Added 2 months ago

Search all journal articles for Parkinson's disease
 

Clinical trials

A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease

This is a Phase 2, multicenter, double-blind, placebo-controlled, parallel-group study consisting of a screening period of up to 4 weeks, a 4 week randomized double-blind, dose-titration treatment period, followed by a 1 week safety...

Added 4 months ago

A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

This is a phase 2 study designed to assess the safety, tolerability and efficacy of NLY01 in subjects with early untreated Parkinson's disease (PD). Evidence suggests NLY01, a pegylated form of exenatide, may be beneficial in PD...

Added 2 months ago

Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

This is a pilot, hypothesis-generating study to explore the effects of pimavanserin and low-dose quetiapine in subjects with Parkinson's disease with neuropsychiatric symptoms.

Added 2 months ago

Search all clinical trials for Parkinson's disease
 
Dr Cornelia Meisenberg

Dr Conny Meisenberg is a medical writer at EPG Health. She joined EPG Health in 2019 following 7 years of postdoctoral research in the oncology field.

Progressive Supranuclear Palsy (PSP)

What is Progressive Supranuclear Palsy (PSP)? Review the causes, treatment and current trials for this uncommon, degenerative disorder.

CME

New Parkinson's drug, SGLT2s as monotherapy: prescribing update June 2016

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Parkinson's disease: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

Parkinson's disease: initial assessment and referral

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Parkinson's disease